Robot-Based Gait Training for Cerebral Palsy
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether a robotic device called the CPWalker can improve walking abilities in children and young adults with cerebral palsy. Participants will undergo several training sessions using the CPWalker to determine if it makes walking easier and more efficient. The trial targets individuals diagnosed with spastic diplegia, a type of cerebral palsy, who can walk but face challenges. Participants should be able to follow simple instructions and communicate clearly about any pain or discomfort. Joining this trial could be a valuable opportunity to try a new kind of therapy.
As an unphased trial, this study offers a unique chance to explore innovative therapy options that could enhance mobility and quality of life.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, it does mention that ongoing botox injections are not allowed.
What prior data suggests that the CPWalker is safe for pediatric patients with cerebral palsy?
Research has shown that using robots like the CPWalker to assist people with cerebral palsy in walking is generally safe. One study examined adults with cerebral palsy and found this type of training safe during an 11-day hospital stay. Although this study focused on adults, it suggests that using robots for walking practice presents few safety issues.
For children with cerebral palsy, another study tested robot-assisted walking training and found it could improve walking ability without major safety concerns. While these studies didn't report specific negative effects, participants tolerated the treatments well.
It is important to note that the CPWalker is still undergoing testing to determine its effectiveness for children, so safety information continues to be collected. However, existing research suggests that robot-based training could be a safe way to help children with cerebral palsy improve mobility.12345Why are researchers excited about this trial?
Unlike traditional therapies for cerebral palsy, such as physical therapy and medication, the CPWalker is a robotic-assisted device that offers a unique approach to gait training. This cutting-edge technology allows for precise, repeatable movements tailored to each individual's needs, potentially enhancing motor learning and coordination in ways that manual therapy cannot match. Researchers are excited because the CPWalker could provide more consistent and intensive training, possibly leading to improved mobility outcomes for children with cerebral palsy in a shorter timeframe.
What evidence suggests that the CPWalker is effective for gait training in cerebral palsy?
Studies have shown that robotic-assisted walking training can help children with cerebral palsy improve their walking ability. This training is particularly beneficial for children with diplegic cerebral palsy, as it enhances their walking over time. Although some reviews note that researchers are still learning about its full effects, early results are promising. In this trial, participants will use the CPWalker, a robotic device that supports and guides a child's legs during walking sessions, helping to strengthen muscles and improve movement. Overall, robotic-assisted walking training offers a hopeful new approach to helping kids with cerebral palsy walk better.13678
Who Is on the Research Team?
Arun Jayaraman, PT, PhD
Principal Investigator
Shirley Ryan AbilityLab
Are You a Good Fit for This Trial?
This trial is for children and young adults aged 11-21 with Cerebral Palsy, specifically spastic diplegia. They should weigh no more than 75kg, be between approximately 110cm to 170cm tall, and have a certain level of motor function (GMFCS score of 2-4). Participants must understand verbal instructions and fit the CPWalker's size requirements. Those with recent surgeries, ongoing botox treatments, severe deformities or cognitive impairments that prevent understanding exercises are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Testing
Baseline testing sessions to assess initial gait parameters and functional mobility
Treatment
Participants engage in an 8-week CPWalker training program with 16-24 sessions
Post-training Testing
Post-training testing sessions to evaluate changes in gait and functional mobility
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- CPWalker
Find a Clinic Near You
Who Is Running the Clinical Trial?
Shirley Ryan AbilityLab
Lead Sponsor